These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 89124)

  • 21. The effect of antacid and ranitidine on droxicam pharmacokinetics.
    Bartlett A; Costa A; Martínez L; Roser R; Sagarra R; Sánchez J
    J Clin Pharmacol; 1992 Dec; 32(12):1115-9. PubMed ID: 1487550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Piroxicam: a review of its pharmacological properties and therapeutic efficacy.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1981 Sep; 22(3):165-87. PubMed ID: 7021122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and biotransformation of methane sulphonanilides with anti-inflammatory activity in the rat and monkey--comparison with piroxicam.
    Krause W; Kühne G; Schillinger E
    Xenobiotica; 1983 May; 13(5):265-72. PubMed ID: 6636822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of isoxicam: a new nonsteroidal anti-inflammatory drug.
    Downie WW
    Singapore Med J; 1985 Feb; 26(1):29-33. PubMed ID: 3895443
    [No Abstract]   [Full Text] [Related]  

  • 26. [Scientific basis of piroxicam (Felden). Pharmacological properties and mechanism of action].
    Wiseman EH
    Wien Med Wochenschr; 1980; 130 Spec No():27-31. PubMed ID: 7456463
    [No Abstract]   [Full Text] [Related]  

  • 27. Disposition of ampiroxicam, a prodrug of piroxicam, in man.
    Falkner FC; Twomey TM; Borgers AP; Garg D; Weidler D; Gerber N; Browder IW
    Xenobiotica; 1990 Jun; 20(6):645-52. PubMed ID: 2219958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.
    Verbeeck RK
    Clin Pharmacokinet; 1990 Jul; 19(1):44-66. PubMed ID: 2199127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of effect of tenoxicam on glibornuride kinetics and response.
    Stoeckel K; Trueb V; Dubach UC; Heintz RC; Ascalone V; Forgo I; Hennes U
    Br J Clin Pharmacol; 1985 Feb; 19(2):249-54. PubMed ID: 3157397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis.
    Trnavská Z; Trnavský K; Zlnay D
    Eur J Clin Pharmacol; 1984; 26(4):457-61. PubMed ID: 6734706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of antacids on salicylate kinetics.
    Shastri RA
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):480-4. PubMed ID: 4055159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative bioavailability study to estimate the influence of an antacid on droxicam pharmacokinetics.
    Maya MT; Pais JP; Ruas Da Silva J; Morais JA
    Eur J Drug Metab Pharmacokinet; 1995; 20(4):275-9. PubMed ID: 8983932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nabumetone--a novel anti-inflammatory drug: the influence of food, milk, antacids, and analgesics on bioavailability of single oral doses.
    von Schrader HW; Buscher G; Dierdorf D; Mügge H; Wolf D
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):311-21. PubMed ID: 6688407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma protein binding and interaction studies with piroxicam.
    Trnavská Z; Trnavský K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):81-5. PubMed ID: 6493354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man.
    Kwan KC; Breault GO; Davis RL; Lei BW; Czerwinski AW; Besselaar GH; Duggan DE
    J Pharmacokinet Biopharm; 1978 Dec; 6(6):451-76. PubMed ID: 731412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of sudoxicam and aspirin in animals and man.
    Wiseman EH; Chang YH; Hobbs DC
    Clin Pharmacol Ther; 1975 Oct; 18(4):441-8. PubMed ID: 809225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of antacids on the clinical pharmacokinetics of drugs. An update.
    Gugler R; Allgayer H
    Clin Pharmacokinet; 1990 Mar; 18(3):210-9. PubMed ID: 1969784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic factors as causes of variability in response to non-steroidal anti-inflammatory drugs.
    Brune K
    Agents Actions Suppl; 1985; 17():59-63. PubMed ID: 3879100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excretion and metabolism of a nonsteroidal antiinflammatory agent, 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxanilide 1,1-dioxide, in rat, dog, monkey, and man.
    Chiaini J; Wiseman EH; Lombardino JG
    J Med Chem; 1971 Dec; 14(12):1175-7. PubMed ID: 5000562
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiinflammatory activity and bioavailability of percutaneous piroxicam.
    Schiantarelli P; Cadel S; Acerbi D; Pavesi L
    Arzneimittelforschung; 1982; 32(3):230-5. PubMed ID: 7200781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.